Network Pharmacology and Experimental Validation to Explore Mechanism of Tetrahydropalmatine on Acute Myocardial Ischemia

被引：0
|
作者：
Po-li Lin
Jun-ling Cao
Ping Ren
Jia-li Chen
Bo-ya Cao
Ping He
Chang-hui Zheng
Qi-wen Li
Wei Wang
Jian Zhang
机构：
[1] Beijing University of Chinese Medicine,School of Chinese Materia Medica
[2] Beijing University of Chinese Medicine,Department of Pharmacy, Dongfang Hospital
[3] Beijing University of Chinese Medicine,School of Chinese Medicine
[4] Beijing University of Chinese Medicine,School of Life Sciences
[5] Guangzhou University of Chinese Medicine,School of Basic Medical Sciences
[6] Beijing Key Laboratory of TCM Syndrome and Formula,Key Laboratory of Beijing University of Chinese Medicine
[7] Ministry of Education,undefined
来源：
Chinese Journal of Integrative Medicine | 2023年 / 29卷
关键词：
tetrahydropalmatine; acute myocardial infarction; inflammation; energy metabolism; hormone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1087 / 1098
页数：11
相关论文
共 50 条
  • [31] Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy
    Ma, Yu
    Deng, Yuanyuan
    Li, Na
    Dong, Ao
    Li, Hongdian
    Chen, Shu
    Zhang, Sai
    Zhang, Mianzhi
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 302
  • [32] Network Pharmacology Analysis and Experimental Validation to Explore the Anti-inflammatory Mechanism of Asiatic Acid on Alcoholic Steatohepatitis
    Jiang, Tao
    Xu, Jinhong
    Lu, Yang
    Chen, Xiaojin
    Li, Yongxia
    MEDIATORS OF INFLAMMATION, 2022, 2022
  • [33] Combining Network Pharmacology, Molecular Docking and Experimental Validation to Explore the Effects and Mechanisms of Indirubin on Acute Lymphoblastic Leukemia
    Jin, Lu
    Guan, Yunshuang
    Li, Xue
    Wang, Mingyue
    Shen, Ying
    Wang, Nianxue
    He, Zhixu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1083 - 1103
  • [34] Mechanism Investigation of Tianxiangdan Against Myocardial Ischemia Based on Network Pharmacology, Molecular Docking, and in vitro Experimental
    Jiang, Lin
    Yue, Yuan-Jia
    Tang, Mei
    Wu, Yu-Che
    Liu, Xiao
    Li, Yu
    PHARMACOGNOSY MAGAZINE, 2024, 20 (03) : 784 - 793
  • [35] Investigation of the protective mechanism of leonurine against acute myocardial ischemia by an integrated metabolomics and network pharmacology strategy
    Rong, Weiwei
    Li, Jiejia
    Wang, Lifeng
    Luo, Shanshan
    Liang, Tulu
    Qian, Xunjia
    Zhang, Xiaodan
    Zhou, Qinbei
    Zhu, Yizhun
    Zhu, Qing
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [36] Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Wogonoside in acute myocardial ischemia rats
    Feng, Wenzhong
    Duan, Cancan
    Pan, Fuzhu
    Yan, Caiying
    Dong, Hongjing
    Wang, Xiao
    Zhang, Jianyong
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 317
  • [37] Exploring Myocardial Ischemia-Reperfusion Injury Mechanism of Cinnamon by Network Pharmacology, Molecular Docking, and Experiment Validation
    Xue T.
    Xue Y.
    Fang Y.
    Lu C.
    Fu Y.
    Lai Z.
    Qin X.
    Huang F.
    Zeng Z.
    Huang J.
    Computational and Mathematical Methods in Medicine, 2023, 2023
  • [38] To Explore the Mechanism and Experimental Verification of Brucine Inhibition of Glioblastoma Based on Network Pharmacology
    Xu, Shaoyan
    Jiang, Hairong
    Zhang, Peng
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2024, 20 (06)
  • [39] Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer
    Zhao, Mei
    Fu, Lijuan
    Xu, Panling
    Wang, Ting
    Li, Ping
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 901 - 917
  • [40] Integrating network pharmacology and experimental validation to explore the potential mechanism by which resveratrol acts on osimertinib resistance in lung cancer
    Yu, Xin
    Yao, Yuan
    Zhou, Haiwen
    Zhu, Jintao
    Zhang, Nini
    Sang, Shuliu
    Zhou, Hailun
    ONCOLOGY LETTERS, 2025, 29 (04)
12345